Fluorescent Antibody Technique, Indirect
"Fluorescent Antibody Technique, Indirect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
| Descriptor ID |
D019084
|
| MeSH Number(s) |
E01.370.225.500.607.512.240.310 E01.370.225.750.551.512.240.310 E05.200.500.607.512.240.310 E05.200.750.551.512.240.310 E05.478.583.375.310
|
| Concept/Terms |
Fluorescent Antibody Technique, Indirect- Fluorescent Antibody Technique, Indirect
- Indirect Fluorescent Antibody Technic
- Immunofluorescence Technique, Indirect
- Immunofluorescence Techniques, Indirect
- Indirect Immunofluorescence Technique
- Indirect Immunofluorescence Techniques
- Immunofluorescence Antibody Test, Indirect
- Indirect Immunofluorescence Assay
- Assay, Indirect Immunofluorescence
- Assays, Indirect Immunofluorescence
- Immunofluorescence Assay, Indirect
- Immunofluorescence Assays, Indirect
- Indirect Immunofluorescence Assays
- Immunofluorescence Technic, Indirect
- Immunofluorescence Technics, Indirect
- Indirect Immunofluorescence Technic
- Indirect Immunofluorescence Technics
- Fluorescent Antibody Technic, Indirect
- Indirect Fluorescent Antibody Technique
Indirect Immunofluorescence- Indirect Immunofluorescence
- Immunofluorescence, Indirect
- Immunofluorescences, Indirect
- Indirect Immunofluorescences
|
Below are MeSH descriptors whose meaning is more general than "Fluorescent Antibody Technique, Indirect".
Below are MeSH descriptors whose meaning is more specific than "Fluorescent Antibody Technique, Indirect".
This graph shows the total number of publications written about "Fluorescent Antibody Technique, Indirect" by people in this website by year, and whether "Fluorescent Antibody Technique, Indirect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 7 | 7 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 3 | 3 |
| 2002 | 1 | 4 | 5 |
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 7 | 7 |
| 2006 | 1 | 3 | 4 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluorescent Antibody Technique, Indirect" by people in Profiles.
-
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis. 2022 08; 81(8):1143-1150.
-
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care Res (Hoboken). 2019 07; 71(7):893-902.
-
ROS-mediated EB1 phosphorylation through Akt/GSK3? pathway: implication in cancer cell response to microtubule-targeting agents. Oncotarget. 2014 May 30; 5(10):3408-23.
-
Sustained activation of protein kinase C induces delayed phosphorylation and regulates the fate of epidermal growth factor receptor. PLoS One. 2013; 8(11):e80721.
-
A synthetic connexin 43 mimetic peptide augments corneal wound healing. Exp Eye Res. 2013 Oct; 115:178-88.
-
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum. 2012 Nov; 64(11):3677-86.
-
Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest Ophthalmol Vis Sci. 2011 Aug 16; 52(9):6452-61.
-
Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-a in the retina. Invest Ophthalmol Vis Sci. 2011 Apr; 52(5):2577-83.
-
Effective and sustained delivery of hydrophobic retinoids to photoreceptors. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11):5958-64.
-
Neuronal localization of m1 muscarinic receptor immunoreactivity in the rat basolateral amygdala. Brain Struct Funct. 2010 Jul; 215(1):37-48.